Enter keywords that you are searching
Publication Date:
8/12/2020
Post Date: 8/12/2020

CARB-X is awarding up to US$2.91 million to Evotec SEa drug discovery and development company in Germany, to develop a new class of antibiotics to treat infections caused by deadly multidrug-resistant Gram-positive and Gram-negative bacteria.

Publication Date:
8/12/2020
Post Date: 8/12/2020

The Massachusetts General Hospital in collaboration with colleagues at University College London, the Harvard T.H.

Tags:
Publication Date:
8/10/2020
Post Date: 8/10/2020

A five-year-old boy who was treated in the emergency department at Children's National Hospital in Washington, DC. is believed to be the first case of antibiotic-resistant bacterial meningitis.  The child was treated with broad-spectrum antibiotics and released after 7 days in the hospital. The susceptibility testing of bacterial samples from the child revealed resistance to five antibiotics—including penicillin and ciprofloxacin.,

Publication Date:
8/7/2020
Post Date: 8/7/2020

Traditional medical care will likely look very different in the post-pandemic world. Routine medical care and even surgery and childbirth may be performed in an office or home setting, as patients seek to reduce exposure to COVID-19 and other infectious agents. As more technology necessary for medical care beomes accessbile and mobile, the treatment platforms will transition to less centralized care.

Tags:
Publication Date:
8/7/2020
Post Date: 8/7/2020

In the unprecedented time of the COVID-19 global pandemic, scientists are self-administering their own vaccines in an effort to hasten the discovery of an effective vaccine. The fringe practice has a long history in medicine, albeit controversial and questionable, by a number of notable researchers. 

Tags:
Publication Date:
8/6/2020
Post Date: 8/6/2020

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen consisting of the antiviral remdesivir plus the immunomodulator interferon beta-1a in patients with coronavirus disease 2019 (COVID-19) has begun. The study, called the Adaptive COVID-19 Treatment Trial 3 (ACTT 3), is anticipated to enroll more than 1,000 hospitalized adults with COVID-19 at as many as 100 sites in the United States and abroad. 

Tags:
Publication Date:
8/6/2020
Post Date: 8/6/2020

A recent study developed an in-facility mortality risk score that reflects Ebola Disease clinical severity and can assist in the clinical prioritization of Ebola patients. The study used the anonymized medical records of 1,077 laboratory-confirmed pediatric and adult EVD patients who received treatment at the 34 Military Hospital and Police Training School Ebola Treatment Centers in Sierra Leone between the period of June 2014 to April 2015.

Publication Date:
8/6/2020
Post Date: 8/6/2020

 Four cases of Dengue fever have recently been confirmed in the Florida Keys, bringing the total number of cases reported this year to 26, health officials. Most of the cases are located around Key Largo. 

Tags:
Publication Date:
8/6/2020
Post Date: 8/6/2020

The World Health Organization (WHO) released one of its influenza reports for the Southern Hemisphere. The ongoing COVID-19 pandemic may be impacting the ability for public health experts to report influenza cases. Globally, influenza activity was reported at lower levels than expected for this time of the year. Of the few respiratory specimens that tested positive for flu in the first half of July, 57.8% were influenza A, and of the subtyped influenza A viruses, all were 2009 H1N1. Of the two characterized influenza B viruses, both were from the Victoria lineage.

 

 

Tags:
Publication Date:
7/30/2020
Post Date: 7/30/2020

A study published in the International Journal of Infectious Diseases demonstrated the 23-valent polysaccharide pneumococcal vaccine (PPV23) protects against adverse cardiovascular events, including heart attacks and congestive heart failure, according to a meta-analysis of 18 studies.  

Tags: